↓ Skip to main content

Do selective serotonin receptor inhibitor antidepressants reduce tamoxifen's effectiveness and increase the risk of death from breast cancer?

Overview of attention for article published in Breast Cancer Research, December 2010
Altmetric Badge

Mentioned by

wikipedia
2 Wikipedia pages

Citations

dimensions_citation
7 Dimensions

Readers on

mendeley
20 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Do selective serotonin receptor inhibitor antidepressants reduce tamoxifen's effectiveness and increase the risk of death from breast cancer?
Published in
Breast Cancer Research, December 2010
DOI 10.1186/bcr2747
Pubmed ID
Authors

Kathleen I Pritchard

Mendeley readers

The data shown below were compiled from readership statistics for 20 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Chile 1 5%
Portugal 1 5%
Unknown 18 90%

Demographic breakdown

Readers by professional status Count As %
Researcher 4 20%
Student > Bachelor 4 20%
Student > Postgraduate 3 15%
Other 2 10%
Professor > Associate Professor 2 10%
Other 5 25%
Readers by discipline Count As %
Medicine and Dentistry 9 45%
Agricultural and Biological Sciences 4 20%
Pharmacology, Toxicology and Pharmaceutical Science 2 10%
Psychology 2 10%
Biochemistry, Genetics and Molecular Biology 1 5%
Other 1 5%
Unknown 1 5%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 March 2019.
All research outputs
#7,468,944
of 22,833,393 outputs
Outputs from Breast Cancer Research
#879
of 1,901 outputs
Outputs of similar age
#54,690
of 182,416 outputs
Outputs of similar age from Breast Cancer Research
#12
of 26 outputs
Altmetric has tracked 22,833,393 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,901 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.8. This one is in the 40th percentile – i.e., 40% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 182,416 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 27th percentile – i.e., 27% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 26 others from the same source and published within six weeks on either side of this one. This one is in the 23rd percentile – i.e., 23% of its contemporaries scored the same or lower than it.